Vical Incorporated (NASDAQ: VICL) is focused on researching and developing biopharmaceutical products designed to prevent and treat serious or life-threatening diseases. Possible applications of the company’s DNA delivery technology include DNA vaccines for infectious diseases or cancer, cancer immunotherapeutics, and cardiovascular therapies. By strategically partnering with other pharmaceutical companies and biotechnology companies, the company hopes to expand its product pipeline. For further information, visit the Company’s web site at www.vical.com.
- 18 years ago
QualityStocks
Vical Incorporated (NASDAQ: VICL)
Tags Rodman & Renshaw
Related Post
-
Greenland Mines Ltd. (NASDAQ: GRML) Advances World-Class Palladium Deposit with Major Resource Upgrade
The combination of a structurally concentrated supply base, rising geopolitical risk from the dominant Russian…
-
Regentis Biomaterials Ltd. (NYSE American: RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3 Billion Cartilage Repair Market
Regentis is targeting an estimated $3 billion U.S. cartilage repair market opportunity, supported by approximately…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Is Building a Modern Public Safety Platform by Integrating Tools, Training and Policy
Wrap Technologies treats non-lethal response as a system rather than a single device, integrating tools,…